DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency for $106,636.46 to supply MACI 3CM X 5CM IMPLANT SHEET 2S. The delivery order has a completion date of December 4, 2023 and was awarded on November 9, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to provide pharmaceuticals and medical supplies including atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, and midazolam hydrochloride to support military treatment facilities worldwide. No set-aside designation was used for this delivery order award.
Generated 2/8/24, 9:29 AM